Avacincaptad Pegol Sodium Patent Expiration
Avacincaptad Pegol Sodium is Used for treating geographic atrophy secondary to age-related macular degeneration. It was first introduced by Astellas Pharma Us Inc
Avacincaptad Pegol Sodium Patents
Given below is the list of patents protecting Avacincaptad Pegol Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Izervay | US11273171 | Methods for treating or preventing ophthalmological conditions | Jul 11, 2034 | Astellas |
| Izervay | US11491176 | Methods for treating or preventing ophthalmological conditions | Jul 11, 2034 | Astellas |
| Izervay | US12016875 | Methods for treating or preventing ophthalmological conditions | Jul 11, 2034 | Astellas |
| Izervay | US8236773 | Aptamer therapeutics useful in the treatment of complement-related disorders | Nov 11, 2026 | Astellas |
| Izervay | US10947544 | Aptamer therapeutics useful in the treatment of complement-related disorders | Feb 14, 2025 | Astellas |
| Izervay | US7538211 | Aptamer therapeutics useful in the treatment of complement-related disorders | Feb 14, 2025 | Astellas |
| Izervay | US7579456 | Aptamer therapeutics useful in the treatment of complement-related disorders | Feb 14, 2025 | Astellas |
| Izervay | US7803931 | Aptamer therapeutics useful in the treatment of complement-related disorders | Feb 14, 2025 | Astellas |
| Izervay | US9617546 | Aptamer therapeutics useful in the treatment of complement-related disorders | Feb 14, 2025 | Astellas |
Avacincaptad Pegol Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List